EXACERBATION DATA

 

BREO—The only ICS/LABA
proven to reduce
exacerbations
without
a second daily dose

 

Proven to reduce the RISK and RATE of exacerbations3*

In a 24- to 76-week study of patients with a history of asthma exacerbations

*Asthma exacerbation=a deterioration of asthma requiring the use of systemic corticosteroids for at least 3 days or on an inpatient hospitalization or ED visit due to asthma that required systemic corticosteroids.
 
Study Design
 
 

Looking for samples?
Looking for a savings offer?
Subject to eligibility. Restrictions apply.

 

Chat